Drug and Therapeutics Committees - A Practical Guide
(2003; 155 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentAcronyms and abbreviations
Afficher le documentPreface
Ouvrir ce répertoire et afficher son contenu1. Introduction
Ouvrir ce répertoire et afficher son contenu2.Structure and organization of a drug and therapeutics committee
Fermer ce répertoire3. Managing the formulary process
Afficher le document3.1 The formulary process
Afficher le document3.2 The formulary list (essential medicines list)
Afficher le document3.3 Formulary manual
Afficher le document3.4 Standard treatment guidelines (STGs)
Afficher le documentAnnex 3.1 Application forms to be filled in by applicants when applying for a new drug to be added to the hospital formulary list
Afficher le documentAnnex 3.2 Drug information included in a comprehensive formulary
Ouvrir ce répertoire et afficher son contenu4.Assessing new medicines
Ouvrir ce répertoire et afficher son contenu5.Ensuring medicine safety and quality
Ouvrir ce répertoire et afficher son contenu6.Tools to investigate the use of medicines
Ouvrir ce répertoire et afficher son contenu7.Promoting the rational use of medicines
Ouvrir ce répertoire et afficher son contenu8.Antimicrobials and injections
Ouvrir ce répertoire et afficher son contenu9. Getting started
Afficher le documentGlossary1
Afficher le documentReferences
Afficher le documentFurther reading
Afficher le documentUseful addresses and websites
Afficher le documentBack cover
 

3.1 The formulary process

The formulary process is the cornerstone of good pharmaceutical management and rational drug use. It consists of preparing, using and updating a formulary list (essential medicines list, EML, or essential drugs list, EDL), a formulary manual (providing information on drugs in the formulary list) and standard treatment guidelines (STGs). Choosing the most appropriate therapies and selecting the most cost-effective good-quality drugs leads to better quality of care and more efficient, equitable use of resources.

Strict adherence to a formulary list alone will not improve treatment practice if drug selection is not based on STGs (i.e. if there is no consistency between the formulary list and the STGs). Furthermore, essential medicines can also be used inappropriately if there are no guidelines for disease management. Ideally, a formulary list should be developed after the appropriate treatment guidelines for common diseases have been identified or developed. In many countries, there are already national STGs and other texts on standard treatment protocols that can be followed and used as a starting point when developing a hospital formulary list or local STGs. Once a formulary list is established, a formulary manual, containing information on all the medicines in the formulary list, can be developed. Figure 3.1 shows the relationship between STGs and EMLs and how these affect respectively the use and the availability of medicines.


Figure 3.1 How STGs and EMLs lead to better prevention and care

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013